China SXT Pharmaceuticals... (SXTC)
Company Description
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China.
The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.
It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands.
As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China.
The company was founded in 2005 and is headquartered in Taizhou, China.
| Country | CN |
| IPO Date | Jan 4, 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 75 |
| CEO | Feng Zhou |
Contact Details
Address: 178 North Taidong Road Taizhou, CN | |
| Website | https://www.sxtchina.com |
Stock Details
| Ticker Symbol | SXTC |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001723980 |
| CUSIP Number | G2161P108 |
| ISIN Number | VGG2161P1403 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Feng Zhou | Chairman of the Board & Chief Executive Officer |
| Xiaodong Pan | Chief Financial Officer |
| Jun Zheng | Executive Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 27, 2025 | 6-K | Filing |
| Jan 23, 2025 | 6-K | Filing |
| Jan 21, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Oct 25, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 22, 2024 | F-3 | Filing |
| Oct 15, 2024 | 6-K | Filing |
| Aug 15, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2024 | 20-F | Filing |
| Jul 31, 2024 | NT 20-F | Filing |
| May 31, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |